We are the International AIDS Society
We convene, educate and advocate for a world in which HIV no longer presents a threat to public health and individual well-being.
Find out more
IAS 2025, the 13th IAS Conference on HIV Science registration and activity submissions are now open!
The IAS unites the global HIV response because progress happens when science, policy and activism come together. Here’s how we do this:
IAS 2025
The 13th IAS Conference on HIV Science
IAS 2025, the 13th IAS Conference on HIV Science, will take place in Kigali, Rwanda, from 13 to 17 July 2025. Pre-meetings will be held on 13 July. An estimated 6,000 participants from around the world will attend IAS 2025.
View detailsEvents
6 Apr 2025
Person-Centred Care Advocacy Academy: HIV in the southern United States
April 2025
Atlanta, Georgia
This Person-Centred Care Advocacy Academy will take place over two and a half days in Atlanta, Georgia, USA, in April 2025. The purpose of the academy is to support its fellows – advocates, activists and (community) healthcare providers – to understand the principles of person-centred service delivery approaches for HIV, learn how to assess HIV service delivery gaps in their settings, and enhance their HIV-related advocacy skills.
View details View details6 May 2025
Académie Scientifique du Vaccin contre le VIH 2025
L'Académie Scientifique du Vaccin contre le VIH vise à soutenir les chercheur·euse·s en début et en milieu de carrière qui mènent des recherches sur le vaccin contre le VIH en Afrique en leur offrant des possibilités de formation, de mise en réseau et de mentorat. L'Académie est conçue pour aider les participant·e·s à s'établir en tant que chercheur·euse·s indépendant·e·s et chef·fe·s d'équipe dans leurs institutions d'accueil respectives.
View details View details3 Jun 2025
2025 HIV Vaccine Science Academy
The HIV Vaccine Science Academy aims at supporting early- and mid-career investigators conducting HIV vaccine research in Africa by providing opportunities for training, networking and mentorship. The Academy is designed to support the participants in establishing themselves as independent researchers and team leaders in their respective host institutions, thus contributing to long-term continuity, networking and research ownership in central, eastern, southern and western Africa in the effort to develop a safe and effective HIV vaccine.
View details View detailsSee us make a difference
Sign up to receive our newsletter. Stay updated on our efforts and impact and learn how to make a difference.
News release
IAS Digest: Improving access
Newsletter
Newsletter
Meet the Mark Wainberg Fellows
“The knowledge I gained from the fellowship has been instrumental in my work to improve the care and support for people living with HIV.”
Read more
Shamim Mohamed
The IAS at a glance
We unite scientists, policy makers and activists to galvanize the scientific response, build global solidarity and enhance human dignity for all people living with and affected by HIV. Here are some numbers that show how we do that.
676
IAS change makers. Carefully selected HIV researchers, advocates, healthcare providers and others help us drive an evidence-based HIV response that puts people first.
17,000+
IAS Members worldwide. We convene people from diverse backgrounds to drive a shared vision of a world in which HIV is no longer a threat to public health and individual well-being.
4,219
Scientific studies shared through our conferences and the Journal of the International AIDS Society in 2022/23. We advocate for evidence-based progress to improve the lives of people living with and affected by HIV.
Quick links to our activities
Closing scientific gaps
Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global HIV Vaccine Enterprise Towards an HIV CureDisseminating the latest research
IAS Educational Fund Journal of the International AIDS Society (JIAS)Improving health services
Community-Led Monitoring Differentiated Service Delivery Heart of Stigma Mark Wainberg Fellowship Programme Person-Centred Care Youth HubThe IAS promotes the use of non-stigmatizing, people-first language. The translations are all automated in the interest of making our content as widely accessible as possible. Regretfully, they may not always adhere to the people-first language of the original version.